Signs of Radon Exposure: What Homeowners Need to Know
Despite the popular search term “signs of radon exposure,” radon exposure does not cause acute toxic symptoms or any other detectable personal sign. There is no symptom, sensation, or observable change in the body that announces radon exposure to the exposed person. The only known health effect of radon exposure is increased long-term lung cancer risk, manifesting five to twenty-five or more years after sustained elevated exposure. EPA and the Surgeon General estimate radon causes approximately 21,000 lung cancer deaths per year in the United States — the second leading cause of lung cancer after smoking. Any respiratory symptom, persistent cough, or lung-related concern should be evaluated by a physician immediately; symptoms are not caused by recent radon exposure and require independent medical evaluation. The only sign of radon exposure that exists is the test result itself. This guide summarizes EPA, CDC, and Surgeon General guidance current as of 2026 and explains the test-result-as-only-sign framing.
Why There Are No Personal Signs
Radon is a colorless, odorless, tasteless radioactive noble gas. It produces no sensory perception at any environmental concentration. Inhaled radon decay products deposit alpha-particle energy in lung tissue silently. There is no inflammation, no immune response, no respiratory irritation, no neurological effect, and no sensory cue. The exposed person feels no different on the day of exposure than on any other day. The damage occurs at the molecular level — alpha-particle hits on DNA — and the consequences appear years or decades later as accumulated cell damage progresses through pre-cancerous and cancerous stages to clinically detectable lung cancer.
This biological mechanism is the most important fact about radon exposure. It is not detectable by attention to one’s own body. Subjective monitoring — paying attention to how one feels, looking for “early warning signs” — produces no information at all about radon exposure. The mental model that environmental hazards announce themselves through symptoms applies to many hazards but does not apply to radon. The right mental model for radon is a cumulative-damage statistical risk model, not an acute-exposure symptom model.
The Only Sign Is the Test Result
The single observable sign that a person is being or has been exposed to elevated radon is a radon test of the air in the spaces where the person spends time. The test produces a number in picocuries per liter (pCi/L) that quantifies the indoor concentration over the test period. EPA’s action level is 4.0 pCi/L; the consideration level is 2.0 pCi/L. Results above the action level indicate ongoing exposure that warrants mitigation; results between the levels warrant confirmation testing and consideration of mitigation; results below the consideration level are reassuring but warrant periodic retesting.
The test result is the sign because nothing in the body changes detectably. A person who tests their home and finds 8 pCi/L is being exposed; a person whose home tests 0.5 pCi/L is not. Neither person feels any different. The information about exposure status comes from the air measurement, not from introspection.
Why People Search for “Signs” Anyway
Several factors drive the persistent search. First, most environmental hazards do produce symptoms — carbon monoxide, mold, certain chemicals, infections — and the mental model of “hazards announce themselves” is built up from those examples. Radon is the unusual case. Second, public-health communication about radon is genuinely difficult because the disease is years removed from the exposure; the cause-and-effect chain is not intuitive. Third, search engines surface “symptoms” content because the queries continue to come in, creating a self-perpetuating cycle that EPA, CDC, NIH, and the American Lung Association have not been able to break.
The constructive response is to compare what any “symptoms” page says against the EPA Citizen’s Guide to Radon and the Surgeon General’s health advisory. The authoritative agencies are aligned on the no-symptoms point. Any page that disagrees is operating outside the public-health consensus and should be treated accordingly regardless of its search ranking.
Long-Term Risk by the Numbers
EPA publishes lifetime lung-cancer risk estimates based on sustained residential exposure. At 4 pCi/L, the lifetime risk is approximately 7 deaths per 1,000 people for never-smokers and approximately 62 deaths per 1,000 for current smokers, assuming 70 years of exposure. At 8 pCi/L the risk roughly doubles. At 20 pCi/L it roughly quintuples. The dose-response curve is approximately linear across the residential range with no identified safe threshold.
The smoking-radon interaction is multiplicative. Smokers exposed to elevated radon have lifetime risk roughly nine times that of never-smokers at the same concentration. The combined effect is the reason the Surgeon General’s radon advisory pays particular attention to smoking households. Former smokers retain elevated risk for years after cessation, with the risk gradually declining over time.
Latency: What Five to Twenty-Five Years Looks Like
The lung-cancer latency from radon exposure varies across individuals and exposure histories. Cohort studies of uranium miners, who had higher and more concentrated exposures than residential populations, document cancers appearing 5 to 30 years after exposure began. Residential case-control studies indicate similar latency ranges for the lower-but-sustained exposures typical of indoor environments. The variability reflects the multi-step nature of carcinogenesis — initiating DNA damage, promotion through subsequent cell divisions, progression to a malignant phenotype, and clinical manifestation as a detectable tumor.
The practical implication for a homeowner is that any exposure right now adds to a future risk that will not be apparent for years. The right time to test and mitigate is whenever the question first arises, not after waiting to see if anything happens. The latency is a feature of the biology, not a delay that creates an opportunity to wait and see.
Biomarkers and Lab Tests for Radon
There is no clinical blood test, urine test, or imaging study that detects radon exposure in a living person. Radon does not produce a characteristic biomarker in the way that lead exposure produces an elevated blood-lead level. Some research-grade techniques can detect alpha-particle damage signatures in lung tissue, but those are not clinical tools and are not part of any standard medical workup. A patient who asks their physician for a “test for radon exposure” is asking for something that does not exist as a clinical service.
The right test is the air test of the home. The right medical follow-up after a positive air test is the standard primary-care evaluation and possibly lung-cancer screening for high-risk individuals — not a search for a radon-specific biomarker.
What Symptoms Should Trigger a Physician Visit
Persistent cough lasting more than three weeks, unexplained shortness of breath, chest pain not associated with exertion, coughing up blood, recurrent respiratory infections, and unexplained weight loss all warrant a primary-care physician’s evaluation. The differential diagnosis is broad — asthma, COPD, infection, allergy, and various malignancies including lung cancer from any cause. The workup typically includes imaging and possibly biopsy. None of these symptoms is attributable to recent radon exposure in the acute sense, although a patient with documented long-term radon exposure and active respiratory symptoms is on a higher-risk pathway and the physician will factor that history into the workup.
The key point: any respiratory symptom warrants a physician’s evaluation independent of any radon question. The two diagnostic lanes — testing the air, evaluating the body — are independent and both deserve attention on their own merits. Confusing the lanes typically delays both actions.
How to Take the Test That Is the Only Real Sign
EPA recommends every home be tested at least once. Several pathways exist for Colorado residents. The CDPHE Radon Program distributes free mail-in test kits to Colorado residents while supplies last. The free radon test Colorado guide covers the request process. A paid charcoal kit from a hardware retailer runs $25 to $75. A continuous-monitor test by a certified provider runs $125 to $250. The local radon testing guide covers the paid-provider vetting framework.
Regardless of method, the test must be deployed under EPA-protocol closed-house conditions in the lowest livable level. The result becomes the only sign of exposure that any homeowner can act on.
What to Do If the Sign Is Positive
A test result at or above 4.0 pCi/L meets the EPA action level. The next step is to commission a mitigation system from a certified mitigator. Standard residential sub-slab depressurization runs $1,500 to $3,500 in Front Range markets. The system draws soil gas from beneath the slab and exhausts it above the roofline, typically reducing indoor concentration to below 2 pCi/L. CDPHE maintains a public list of certified mitigators, which is the right starting point for a Colorado homeowner.
Mitigation does not undo prior exposure. The cumulative dose already received cannot be reversed. What mitigation does is eliminate ongoing exposure, which prevents further dose accumulation. Reducing radon at any time reduces future risk even after years of prior exposure.
Concern About Past Exposure
A homeowner who tests a home that has been occupied for years without prior testing and learns of elevated radon is understandably concerned about cumulative exposure. The constructive responses are to mitigate the home, see a primary-care physician for baseline guidance, and consider whether lung-cancer screening is appropriate. Low-dose CT screening is the current standard for high-risk individuals, typically defined by age (50 to 80) and smoking history. The physician will weigh the radon-exposure history alongside other risk factors. No screening protocol is specifically tailored to radon exposure alone, but the same screening tools detect any lung cancer regardless of cause. The radon testing pillar covers the testing-mitigation-monitoring decision sequence in more depth.
How a Test Becomes the Permanent Record
The air-test result that serves as the only sign of exposure also becomes part of the property’s permanent record. Real-estate disclosure laws in Colorado require sellers to disclose known environmental conditions, and a prior radon test result — whether above or below the action level — supports the disclosure obligation. Buyers and their inspectors routinely ask about prior testing during the contract due-diligence period. A documented test history accelerates the disclosure conversation. An absent test history typically triggers a buyer-funded test during the contingency period, which is often a continuous-monitor test costing more than a homeowner-deployed kit would have cost.
The Body Tells You Nothing About Radon
The bottom-line frame for this article is that the body does not signal radon exposure. Looking for body-based signs produces no useful information and often produces anxiety. Looking for the test-result-based sign produces actionable information that a homeowner can mitigate. Switching the search behavior from “signs in my body” to “signs in my home” is the single most important reframing a Front Range homeowner can make on this topic.
References
- EPA health risk of radon — Environmental Protection Agency
- CDC radon overview — Centers for Disease Control and Prevention
- American Lung Association radon resources — Lung.org
- NIH research on residential radon and lung cancer — National Institutes of Health
Front Range homeowners ready to test or mitigate can reach our team through the contact page for a referral.